Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) constitutes a devastating disease spectrum characterized by 43-kDa TAR DNA-binding protein (TDP-43) pathology. Understanding how TDP-43 contributes to neurodegeneration will help direct therapeutic efforts. Here we have created a TDP-43 knock-in mouse with a human-equivalent mutation in the endogenous mouse Tardbp gene. TDP-43 Q331K mice demonstrate cognitive dysfunction and a paucity of parvalbumin interneurons. Critically, TDP-43 autoregulation is perturbed, leading to a gain of TDP-43 function and altered splicing of Mapt, another pivotal dementia-associated gene. Furthermore, a new approach to stratify transcriptomic data by phenotype in differentially affected mutant mice revealed 471 changes linked with improved behavior. These changes included downregulation of two known modifiers of neurodegeneration, Atxn2 and Arid4a, and upregulation of myelination and translation genes. With one base change in murine Tardbp, this study identifies TDP-43 misregulation as a pathogenic mechanism that may underpin ALS-FTD and exploits phenotypic heterogeneity to yield candidate suppressors of neurodegenerative disease.
A myotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are destructive neurodegenerative diseases that exist on a clinicopathological spectrum (ALS-FTD) 1 . ALS is characterized by motor impairment and FTD by executive dysfunction, language impairment and behavioral changes. Nearly all cases of ALS, half of FTD cases, and most hereditary forms of ALS and FTD are characterized by cytoplasmic mislocalization and aggregation of TDP-43 2, 3 . The identification of mutations in the gene encoding TDP-43 (TARDBP) as a cause of ALS and FTD confirmed that TDP-43 plays a mechanistic role in neurodegeneration 4, 5 . This role remains undefined.
TDP-43 is a conserved RNA-binding protein with critical roles in splicing in the nervous system 6 . TDP-43 also demonstrates tight autoregulation by binding to its transcript, triggering alternative splicing of intron 7 in the TARDBP 3′ untranslated region (UTR) and destruction of its mRNA 7 . Experimentally increasing and decreasing TDP-43 levels both cause neuronal loss, but whether human neurodegeneration is caused by a gain or loss of TDP-43 function remains unclear. Modeling of mutant TDP-43 in vivo has relied on variable degrees of transgenic overexpression of TDP-43 to replicate pathological changes seen in postmortem human tissues 8 . However, TDP-43 transgenic mouse models have demonstrated that TDP-43 aggregation is not necessary to cause neurodegeneration 9 , and whether TDP-43 aggregation is causally linked to disease onset is unclear.
A caveat of transgenic TDP-43 mouse models is that phenotypes may partly be artifacts of overexpression. Furthermore, the cell-type-specific expression of single TDP-43 splice forms in transgenic models using neuronal promoters and temporally triggered expression of transgenes in adulthood do not reflect the ubiquitous expression and alternative splicing of Tardbp, including that occurring during embryonic development 10 . To unravel the role of mutant TDP-43 in the disease pathogenesis, we created a knock-in mouse harboring only a human-equivalent point mutation in the endogenous mouse Tardbp gene. This model replicates the human mutant state as closely as possible, retaining the endogenous gene structure TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD and increased rearing and eating by hand, but no alterations in circadian rhythmicity (Fig. 1c ). The most consistent phenotype was reduced walking in males ( Fig. 1d and Supplementary Fig. 1b ). Further breeding revealed an under-representation of male mutants, yet females were present at Mendelian ratios, further suggesting that males are more susceptible to deleterious effects of TDP-43 Q331K (Fig. 1e ). This is notable because sporadic ALS is more common in men, and TDP-43 mutations demonstrate greater penetrance in men than women 15 . We therefore focused on males in subsequent studies, breeding two cohorts of mice: cohort 1 for motor, pathological and transcriptomic studies, cohort 2 for cognitive studies.
TDP-43 Q331K mice display no significant motor impairment, but demonstrate weight gain due to hyperphagia and transcriptomic changes in spinal motor neurons. To identify ALS-like motor deficits, we measured Rotarod performance in cohort 1 mice. From ~6 months of age, TDP-43 Q331K/+ and TDP-43 Q331K/Q331K mice demonstrated reduced Rotarod latencies ( Fig. 2a) . Notably, mutants demonstrated hyperphagia, a feature of FTD 16 , and gained more weight than wild-type mice (Fig. 2b,c) . Increased weight could contribute to impaired Rotarod performance, so we tested cohort 2 mice, which were weight-matched by dietary control ( Supplementary Fig. 2a ). Weight-matched mutants performed similarly to wild-type mice up to 16 months of age ( Fig. 2d ), suggesting that mutant mice do not have significant impairment of motor coordination.
To determine whether mutant mice demonstrate lower motor neuron degeneration, we examined spinal cords from 5-monthold mice to identify early pathological changes. Motor Fig. 1 | CRiSPR mutagenesis, ACBM characterization and breeding ratios of TDP-43 Q331K mice. a, Chromatograms from the patient originally identified with the Q331K mutation and CRISPR/Cas9 knock-in founder mouse 52. Bases are given above the chromatograms and amino acids coded are given below. The mutation is highlighted with the red arrow. b, SapI restriction enzyme digestion of 1,000-bp PCR products across the mutation site from representative genotyping of wild-type, TDP-43 Q331K/Q331K and TDP-43 Q331K/+ mice. c, ACBM of 4-month-old mice (n = 10 mice per genotype; 5 males and 5 females). Significantly altered behaviors are displayed: walking: interaction P < 0.0001; hanging: interaction P = 0.002; rearing: interaction P = 0.038; eating by hand: genotype P = 0.008; repeated measures two-way ANOVA. d, Walking behavior as assessed by ACBM in 7.5-month-old male and female mice (n = 5 mice per genotype). Walking male: interaction P < 0.0001; walking female: interaction P = 0.334; repeated measures two-way ANOVA. e, Ratios of mice genotyped at 10 d (all of which were successfully weaned), by gender. Female: χ 2 = 2.311, d.f. = 2, P = 0.315; male: χ 2 = 7.612, d.f. = 2, P = 0.022; chi-squared test. Error bars represent mean ± s.e.m.
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NATURe NeURoSCieNCe demonstrated normal morphology and numbers, with no TDP-43 aggregation or mislocalization in TDP-43 Q331K/Q331K mice ( Fig. 2e,f and Supplementary Fig. 2b ). Quantification of neuromuscular junctions (NMJs) and succinate dehydrogenase staining in gastrocnemius muscles were normal in TDP-43 Q331K/Q331K mice, suggesting no significant denervation ( Supplementary Fig. 2c ,d,f). Examination of 18-to 23-month-old mice similarly found no evidence of denervation ( Supplementary Fig. 2e ) and no electrophysiological evidence of motor unit loss ( Fig. 2g and Supplementary Fig. 2g-o) .
Collectively, these data indicated a remarkable resilience of neuromuscular units to TDP-43 Q331K . We hypothesized that gene expression changes occurring in motor neurons of mutant mice could elucidate how these cells respond to cellular stress caused by TDP-43 Q331K . We thus isolated RNA from laser-captured lumbar motor neurons from 5-month-old mice and performed RNA sequencing (RNA-seq; Supplementary Fig. 3a,b ). This yielded 31 significant expression and splicing differences between wildtype and TDP-43 Q331K/Q331K mice ( Fig. 2h 
NATURe NeURoSCieNCe function in TDP-43 Q331K/Q331K mice. The largest gene expression change was a threefold increase in expression of aldehyde oxidase 1 (Aox1). Little is known about the neurobiological functions of AOX1, although its transcript has been observed in the anterior horn of the spinal cord 18 . AOX1 catalyzes the conversion of retinaldehyde to retinoic acid [19] [20] [21] , which functions in neuronal maintenance in the adult nervous system and following axon injury. Thus, Aox1 upregulation may benefit motor neurons in TDP-43 Q331K/ Q331K mice. Immunostaining revealed expression of AOX1 in spinal motor neurons ( Fig. 2j ), but no difference in expression between TDP-43 Q331K/Q331K and wild-type mice ( Fig. 2k and Supplementary  Fig. 3f ). This could be because upregulated AOX1 is transported into peripheral motor axons, as we found abundant expression of AOX1 in motor axons ( Fig. 2j ).
TDP-43 Q331K mice display executive dysfunction, memory impairment and phenotypic heterogeneity.
In parallel with motor studies, to determine whether TDP-43 Q331K causes FTD-like cognitive dysfunction we performed neuropsychological assessments on cohort 2 mice using touchscreen operant technology. To test whether mice exhibited FTD-related deficits, we used the five-choice serial reaction time task (5-CSRTT; Fig. 3a ), which measures frontal or executive function, including attention, perseveration, impulsivity and psychomotor speed 22 . At 4 months of age the number of training sessions required to reach performance criteria for probe testing was higher in TDP-43 Q331K/Q331K mice than wild-type mice (Fig. 3b ), indicating learning deficits in mutants. Following training, animals underwent probe testing at 6 and 12 months of age. Accuracy ( Fig.  3c ,d, insets) and omission percentage were comparable between genotypes at 6 months of age ( Fig. 3c ). However, at 12 months of age, while accuracy remained normal, omission percentage was greater in TDP-43 Q331K/+ and TDP-43 Q331K/Q331K mice ( Fig. 3d ), suggesting attentional deficits and cognitive decline in mutants. Reward collection and response latencies, as well as premature and perseverative response rates, were similar between genotypes ( Supplementary  Fig. 4a -h), arguing against visual, motivational or significant motor deficits as causes for increased omissions. We also measured motivation using fixed-ratio and progressive-ratio schedules. No significant differences were found between genotypes, further suggesting that increased omissions in mutants were not due to motivational deficits ( Fig. 3e ,f). Collectively, these data indicate an inattention phenotype in TDP-43 Q331K/+ and TDP-43 Q331K/Q331K mice, which is consistent with frontal or executive dysfunction. Next, to explore temporal-lobe-dependent function, we conducted the spontaneous object recognition task, a test of declarative memory. Initial exploratory times did not differ between genotypes ( Fig. 3g ), but in the choice phase a deficit emerged in TDP-43 Q331K/+ and TDP-43 Q331K/Q331K mice ( Fig. 3h ), indicating memory impairment. The combination of executive dysfunction and memory impairment, together with hyperphagia in free-fed cohort 1 mice, led us to conclude that TDP-43 Q331K/+ and TDP-43 Q331K/Q331K mice recapitulate FTD at the behavioral level. 
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During touchscreen analyses we noted that some cohort 2 mutant mice demonstrated consistently worse performance than other mutants ( Fig. 3b and Supplementary Fig. 4i ). This phenotypic heterogeneity was intriguing given that the mutant mice were genetically homogeneous. Furthermore, ALS-FTD is a remarkably heterogeneous disease in which patients display varying phenotypic severity and different rates of disease progression. Indeed, TARDBP mutation carriers demonstrate variable penetrance even with homozygous mutations 15 . We therefore looked for further evidence of phenotypic heterogeneity by examining cohort 1 mice Interaction P = 0.528, sex P = 0.0003, genotype P < 0.0001
Interaction P = 0.008, sex P < 0.0001, genotype P < 0.0001
Interaction P = 0.530, sex P < 0.0003, genotype P < 0.0081
Interaction P = 0.623, sex P < 0.262, genotype P < 0.0001
Interaction P = 0.012, sex P < 0.002, genotype P < 0.0001 
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NATURe NeURoSCieNCe using the marble-burying assay, a measure of innate digging behavior 23 . From 5 to 18 months of age, wild-type mice buried ~80% of marbles. Mutants demonstrated a range of digging behaviors, with some animals behaving similarly to wild-type mice but others demonstrating attenuated digging behavior ( Fig. 3i and Supplementary  Fig. 4j ). These observations confirm the presence of phenotypic heterogeneity in genetically homogeneous groups of mutant mice and suggest that some mutants were relatively resistant to behavioral deficits caused by TDP-43 Q331K .
TDP-43 Q331K mice demonstrate perturbed TDP-43 autoregulation and reduced parvalbumin-positive neurons.
To obtain mechanistic insight into the cognitive dysfunction in TDP-43 Q331K mice, we conducted pathological and transcriptomic studies at 5 months of age. We first performed the marble-burying assay to identify animals with a range of different behaviors (Fig. 4a ). Analysis of frontal cortices from wild-type and TDP-43 Q331K/Q331K mice demonstrated no significant reduction in cortical thickness or cellular density in mutants ( Fig. 4b and Supplementary  Fig. 5a -c), and no nuclear clearing or cytoplasmic aggregation of TDP-43 ( Fig. 4c ). However, subcellular fractionation and immunoblotting demonstrated a ~45% increase in nuclear TDP-43 in TDP-43 Q331K/Q331K compared to wild-type mice (Fig. 4d,e and Supplementary Fig. 5d ).
TDP-43 has critical roles in RNA processing, which may be disturbed in disease. We therefore performed transcriptomic analyses using RNA-seq of frontal cortices from six wild-type, six TDP-43 Q331K/+ and eight TDP-43 Q331K/Q331K mice ( Supplementary  Fig. 6a ). We identified 171 genes that were upregulated and 233 that were downregulated in TDP-43 Q331K/Q331K mice relative to wildtype ( Fig. 4f,g) . TDP-43 Q331K/+ mice demonstrated changes that trended in the same direction as TDP-43 Q331K/Q331K mice, suggesting a dose-dependent effect of the mutation. In particular, we noted a 14% increase in expression of Tardbp in TDP-43 Q331K/Q331K mice (Fig. 4h ). As nuclear TDP-43 protein expression was also elevated in mutants, we conclude that the Q331K mutation disturbs TDP-43 autoregulation.
One notable gene that was downregulated in mutant mice was Nek1. This change is consistent with human data indicating that loss-of-function mutations in NEK1 cause ALS 24, 25 . Another downregulated gene was Pvalb, which encodes the calcium buffering protein parvalbumin. Reduced parvalbumin immunopositivity is observed in patients with ALS and is linked with selective cellular vulnerability in ALS 26 . We therefore immunostained for parvalbumin and found a ~25% reduction in parvalbumin-positive cells in the frontal cortex of TDP-43 Q331K/Q331K mice (Fig. 4i,j) . Co-staining for TDP-43 in this affected subset of cortical neurons did not demonstrate TDP-43 mislocalization (Fig. 4k,l) . Notably, fast-spiking parvalbumin interneurons are GABAergic inhibitory cells that play a direct role in the control of attention 27 . We therefore conclude that a paucity of parvalbumin interneurons may be responsible for the attentional impairment of TDP-43 Q331K mice. 
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Splicing analysis indicates a gain of function of TDP-43 Q331K and links aberrant TDP-43 homeostasis with altered splicing of Mapt. TDP-43 plays key roles in alternative splicing. We therefore interrogated the cortical transcriptomic dataset further for splicing differences between mutant and wild-type mice and identified 138 splicing changes in 106 genes (Fig. 5a,b and Supplementary Fig. 6b ). This included an ~80% increase in retention of Tardbp intron 7 in TDP-43 Q331K/Q331K mice ( Fig. 5c,d ), which will promote the production of stable mRNA species 7 . This confirms that TDP-43 autoregulation is perturbed in mutant mice. Another prominent change was a 2.4-fold increase in exclusion of Sort1 exon 17b, a known splicing target of TDP-43 ( Fig. 5e,f ). This change is consistent with a gain of function of TDP-43 28 .
We also noted altered splicing of exons 2 and 3 of Mapt, which encodes the microtubule associated protein tau and is mutated in FTD with parkinsonism 29 . We detected increased inclusion of Mapt exons 2 and 3 in TDP-43 Q31K/Q331K mice ( Fig. 5g-i) . This is notable because inclusion of exons 2 and 3 of Mapt is associated with increased somatodendritic localization and aggregation of tau 30 . We immunostained wild-type and mutant frontal cortices for total tau but found no difference in the localization or aggregation of tau ( Supplementary Fig. 6c ). Analysis of iCLIP databases (http://icount. biolab.si/groups.html) revealed that TDP-43 binds to an intronic sequence upstream of Mapt exon 2 (Fig. 5g ). This confirmed that Mapt exons 2 and 3 are likely splicing targets of TDP-43. The identification of this splicing effect of TDP-43 on Mapt mechanistically links these two major dementia genes.
Next, to determine whether TDP-43 misregulation could be responsible for temporal-lobe-dependent functions, we analyzed hippocampal RNA extracts from male mice. We also examined hippocampi from female mice to determine whether TDP-43 misregulation was restricted to male mice. Splicing analyses for Tardbp, Sort1 and Mapt were consistent with a gain of function of TDP-43 in mutant mice of both genders (Fig. 5j,k) . This indicates that TDP-43 misregulation occurs beyond the frontal cortex, and in both male and female mice.
Finally, to confirm that our behavioral and transcriptomic observations were caused by mutant TDP-43 and not off-target CRISPR mutagenesis effects, we performed the marble-burying assay in a second line of TDP-43 Q331K knock-in mice, line 3, and found a similar impairment of digging behavior to line 52 mice ( Supplementary Fig. 6d ). We also analyzed RNA from line 3 mice and observed an increase in Tardbp expression and altered splicing of Tardbp and Sort1, which is consistent with perturbed autoregulation and a gain of function of TDP-43 ( Supplementary Fig. 6e ). Furthermore, line 3 TDP-43 Q331K/Q331K mice also demonstrated increased inclusion of exons 2 and 3 of Mapt and a paucity of parvalbumin-positive neurons relative to wild-type mice, replicating key splicing and pathological observations made in line 52 mice ( Supplementary Fig. 6e,f) .
TDP-43 misregulation in lumbar spinal cords of mutant mice further implicates interneurons in ALS-FTD pathogenesis.
Our transcriptomic profiling of frontal cortices and hippocampi elucidated a gain of function of TDP-43 in the brains of mutant mice. By contrast, spinal motor neurons from mutants did not demonstrate TDP-43 misregulation, as Tardbp, Sort1 and Mapt were not differentially expressed or spliced in these cells (Fig. 6b ). However, TDP-43 misregulation could occur in other cells of the spinal cord, namely glia or interneurons. We therefore analyzed RNA from homogenates of lumbar spinal cord from the mice from which we had laser captured spinal motor neurons (Fig. 6a) . Notably, spinal cord homogenates demonstrated increased expression of Tardbp and altered splicing of Tardbp and Sort1 consistent with a gain of function of TDP-43 in mutant mice (Fig. 6c ). Furthermore, spinal cords from mutant mice also demonstrated increased inclusion of Mapt exon 2 (Fig. 6d) . Given that Mapt expression is predominantly neuronal rather than glial, this suggests that a gain of TDP-43 function occurs in interneurons of the spinal cord. 
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Stratification of transcriptomic data from TDP-43 Q331K/Q331K mice by phenotype identifies expression and splicing changes.
As stated earlier, some mutant mice appeared relatively resistant to the cognitive effects of the Q331K mutation. We wished to exploit this phenotypic heterogeneity in TDP-43 Q331K/Q331K mice to identify potential modifiers of cognitive dysfunction. For this purpose, we divided the frontal cortical transcriptomic data from the eight TDP-43 Q331K/Q331K mice into two subsets according to their antemortem marble-burying behavior. We designated this the 'MB + /-' comparison: TDP-43 Q331K/Q331K mice that dug consistently well were designated MB+ , and those that dug consistently poorly were designated MB- (Fig. 7a,b ). We hypothesized that transcriptomic differences between these two genotypically homogeneous groups would indicate molecular pathways that influence the risk of developing cognitive impairment. Using this strategy, we found 410 gene-expression and 61 splicing differences between MB+ and MB-groups ( Fig. 7c and Supplementary Fig. 6g,h) , which were entirely different from those seen in the earlier comparison with wild-type mice when all eight TDP-43 Q331K/Q331K mice were considered as one group (Figs. 4g  and 5b ). For 78% of these genes, MB+ and MB-mice demonstrated opposing expression changes relative to wild-type ( Fig. 7c and Supplementary Tables 1 and 2 ). Effectively, for these genes, an expression change in one direction is associated with a poor behavioral phenotype yet an expression change in the opposite direction is associated with improved behavior. Furthermore, there was no difference in TDP-43 expression or the degree of TDP-43 gain of function as evidenced by Sort1 splicing between MB+ and MBgroups. Taken together, these data indicate that the MB + /-comparison genes could be metastable modulators of TDP-43-mediated cognitive dysfunction.
Notably, two of the genes from the MB + /-comparison have previously been linked with suppression of neurodegeneration: Atxn2 and Arid4a. Compared to wild-type mice, MB+ mice demonstrated reduced Atxn2 expression, while MB-mice demonstrated increased Atxn2 expression. This is in keeping with previous observations that Atxn2 knockdown suppresses TDP-43 toxicity in yeast, Drosophila and mouse 31, 32 . Furthermore, intermediate expansions of Atxn2 CAG repeat length are associated with ALS disease risk in humans 31 . Similarly, reduced expression of the chromatin-modeling gene Arid4a in MB+ mice is noteworthy, as we previously found that loss-of-function mutations in hat-trick, the Drosophila ortholog of Arid4a, suppress TDP-43-mediated neurodegeneration in flies 12 . It is therefore likely that reduced levels of Atxn2 and Arid4a are similarly neuroprotective in TDP-43 Q331K/Q331K MB+ mice.
To identify the most significant pathways linked with phenotypic heterogeneity in the MB + /-comparison, we cross-referenced the differential gene expression list with the Gene Ontology database for biological processes (Fig. 7c ). Genes downregulated in MB+ mice were enriched for biological processes involving transcription, DNA methylation and chromatin modification. Genes upregulated in MB+ mice were enriched for processes involving protein translation and myelination, including the myelin repair gene Olig1 and Mbp, which encodes myelin basic protein ( Supplementary Table 2 ). Furthermore, examination of the splicing gene list also identified Mbp as a candidate (Fig. 7d,e ). Specifically, MB-mice demonstrated a significantly increased expression of a specific splice form that is predicted to encode Golli-Mbp, in which three additional exons upstream of classical Mbp are normally expressed in nonmyelinating cells, including neurons, and in immature oligodendrocytes 33 . Collectively, this Gene Ontology analysis identifies an association between the upregulation of protein translation and oligodendrocyte genes and improved behavior in TDP-43 Q331K/Q331K mice, and suggests that the promotion of myelin repair pathways by oligodendrocytes in a mature state contributes to improved cognition.
To confirm the validity of MB + /-hits, we deliberately swapped data from the worst-performing MB+ mouse with that of the best-performing MB-mouse. This resulted in all transcriptomic hits disappearing from the analysis (Fig. 7f ). We also compared only the three best-performing MB+ mice with the three worst-performing MB-mice and found a diminished hit list, but one that largely overlapped with the genes from the complete MB + /-comparison. Furthermore, we found two TDP-43 Q331K/Q331K mice that were littermates yet demonstrated contrasting digging behavior on repeated assessment (Fig. 7a,b ). This indicated that transcriptomic differences between MB+ and MB-groups were not due to a genetic founder effect in our breeding program. Collectively, these data indicate that the MB + /-transcriptomic differences were genuinely reflective of two phenotypic subsets of young TDP-43 Q331K/Q331K mice.
TDP-43 Q331K mice demonstrate age-related deterioration of cortical transcriptomes with altered expression and splicing of other ALS-linked genes.
Aging is the greatest known risk factor for sporadic ALS-FTD. To determine the effects of aging on TDP-43 Q331K mice, we performed a frontal cortical RNA-seq study in 20-monthold mice (Fig. 8a,b ,e,f and Supplementary Fig. 7a,b) . Comparison of wild-type and mutant mice revealed transcriptomic differences that partly overlapped with the 5-month-old dataset (Fig. 8c,d,g,h) . Aged mutant mice still demonstrated a gain of function of TDP-43, increased retention of Mapt exons 2 and 3, and reduced Nek1 and Pvalb expression. However, a broader range of transcriptomic changes was seen, further implicating inhibitory interneuronal disturbances, including downregulation of Sirt1 and Ppargc1a, which encode proteins involved in Pvalb transcription, and downregulation of Gad1 (Gad67), which encodes the GABA synthetic protein glutamate decarboxylase ( Supplementary Table 1 ). Aged mice also demonstrated downregulation of Tbk1 (encoding Tank binding protein kinase 1) ( Fig. 8d) , loss-of-function mutations of which cause ALS and FTD 34, 35 . Several other ALS-FTD-linked genes also demonstrated significant downregulation, including Chmp2b, mutations of which cause FTD 36 , Erbb4, mutations of which cause ALS 37 , the ALS risk-linked genes Epha4 and Kifap3 38, 39 , and the TDP-43 nuclear import factor Kpnb1 40 . We also observed altered splicing of ALS-linked genes Matr3 41 (decreased exclusion of exon 14, which encodes a zinc finger domain) and Sqstm1 42 (Fig. 8h-j and Supplementary Fig. 7f,g) . For Sqstm1 (encoding sequestosome 1), two splice variants (major and minor) were detected in wild-type and mutant mice, but a third variant was present only in mutants. This TDP-43 Q331K -specific variant comprises a truncated exon 7 and a 2-bp frameshift in exon 8, which is predicted to introduce a premature stop codon with loss of the C-terminal ubiquitin-associated domain of sequestosome 1 (Fig. 8j ). Furthermore, Gene Ontology and pathway analysis of the RNA-seq dataset in 20-month-old mice revealed many more significant networks than had been identified in 5-month-old TDP-43 Q331K mice. Aged mutants demonstrated changes in processes classically linked to neurodegeneration, including protein ubiquitination, autophagy and glutamate receptor activity, while KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis highlighted "ALS" and immune pathways (Fig. 8b) . These pathways were not invoked in young mice (Fig. 4g) . Collectively, these observations in aged mutant mice validate key transcriptomic findings in young mutants, link aberrant TDP-43 homeostasis with other key ALS-FTD-linked genes, and indicate age-related progressive changes in the cortical transcriptomes of TDP-43 Q331K mice.
Finally, to identify transcriptomic differences associated with long-term resistance to cognitive impairment, we performed an MB + /-comparison in aged mice. As most aged TDP-43 Q331K/Q331K mice had progressed to an MB-state by 20 months, we compared TDP-43 Q331K/+ mice, which we were able to stratify into MB+ and MB-groups. This comparison yielded only 21 differentially expressed genes and 45 splicing differences between TDP-43 Q331K/+ MB+ and MB-mice, which did not overlap with those genes iden-Articles NATURe NeURoSCieNCe tified in the MB + /-comparison of 5-month-old TDP-43 Q331K/Q331K mice ( Supplementary Fig. 7c-e ). This suggests that aged TDP-43 Q331K/+ mice are not amenable to stratification in the same way as young TDP-43 Q331K/Q331K mice, and further suggests that modulation of MB + /-genes early in life has the potential to influence longerterm susceptibility to cognitive impairment secondary to aberrant TDP-43 homeostasis.
Discussion
Here we show that with a single human disease-linked base change in murine Tardbp it is possible to replicate behavioral, pathological and transcriptomic features of the ALS-FTD spectrum. By creating a model that mimics the human mutant state as closely as possible and in the absence of exogenous expression, we determined that the Q331K mutation perturbs TDP-43 autoregulation. This leads to an increase in TDP-43 expression (effectively a gain-of-function defect). Notably, spinal cords from sporadic ALS patients and from TARDBP mutation carriers demonstrate increased TDP-43 mRNA expression, as do human stem-cell-derived motor neurons with TARDBP mutations 43, 44 . This indicates that TDP-43 misregulation could underpin the human disease state.
Lumbar motor neurons of TDP-43 Q331K/Q331K mice demonstrated upregulation of genes that may confer neuroprotection and did not demonstrate TDP-43 misregulation, both of which might explain why mutant mice did not demonstrate significant neuromuscular phenotypes. By contrast, the FTD-like phenotypes in mutant mice were more marked. The identification of reduced parvalbumin expression as a possible cause for cognitive impairment in ALS-FTD is intriguing, as parvalbumin interneuron loss has been observed in sporadic ALS and FTD 26 . As parvalbumin interneurons are GABAergic, a reduction in their numbers could increase activity of cortical projection neurons, with excitotoxic consequences. Early interneuronal dysfunction may have analogous consequences in the spinal cord and is suggested by our observation that TDP-43 autoregulation is perturbed in the spinal cord, but not in motor neurons.
That TDP-43 Q331K mice demonstrate a specific increase in inclusion of Mapt exons 2 and 3 is of great interest, as oligomers of the 2N splice isoform of tau appear to have a greater ability to provoke tau aggregation than 0N and 1N isoforms 30 , and inclusion of exons 2 and 3 influences subcellular localization and protein-protein interactions of tau 45 . Furthermore, in humans the H2 Mapt haplotype is associated with a greater inclusion of Mapt exon 3 and is associated with an earlier age of onset in FTD 46, 47 . Although we did not observe clear disturbances of total tau localization in TDP-43 Q331K mice, more detailed analyses to identify specific tau isoforms are warranted. Our identification of a mechanistic link between TDP-43 and Mapt adds to growing evidence that ALS-FTD is characterized by both TDP-43 and tau pathology 48 . Furthermore, transcriptomic analysis of aged TDP-43 Q331K mice elucidated changes in other ALS-FTD linked genes. Collectively, these findings emphasize a central role for TDP-43 in neurodegeneration.
Finally, we observed phenotypic heterogeneity among mutant mice with the same genotype and identified distinct transcriptomic profiles corresponding to differing phenotypes. This transcriptomic dataset contains genes already implicated in neurodegeneration, including Arid4a 12 and Atxn2 31 . The unbiased discovery of Atxn2 downregulation as a hit in our model is consistent with observations validating Atxn2 knockdown as a therapeutic approach for ALS-FTD 32 . Our data suggest a delicate balance in the transcriptome of the brain, which is metastable and can influence disease onset or progression. Identifying the environmental factors that influence this balance is a priority in future studies. Indeed, the strong representation of DNA methylation and chromatin modeling genes in the MB + /-comparison suggests a critical role for epigenetic influences in determining disease susceptibility. Genes with roles in protein translation and oligodendrocyte biology, including myelina-tion, also featured in our list of putative disease modifiers, and it is encouraging that both these pathways have roles in neurodegenerative disease 49, 50 . Our wider list of potential modifiers of disease is composed of over 450 gene-expression and splicing changes that are associated with improved behavior in TDP-43 Q331K/Q331K mice. We conclude that this list contains additional suppressors of neurodegeneration that will help direct efforts toward developing treatments for ALS-FTD.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41593-018-0113-5.
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Methods CRISPR/Cas9 mutagenesis to introduce the Q331K mutation. Nucleases were designed to be close to or overlap the desired point mutation. Three CRISPR/ Cas9 nucleases were tested for activity using a GFP reporter plasmid. A 121-bp single-stranded DNA oligonucleotide with the point mutation at the midpoint was used as a repair template. Guide RNA (gRNA) and a capped Cas9 mRNA were synthesized and injected with the donor oligonucleotide into 270 single-cell C57Bl/6 J embryos. For sequences see Supplementary Table 3 . Off-targets were predicted using CRISPRseek 51 .
Mouse breeding and maintenance. Mouse founder number 52 was outcrossed with wild-type C57Bl/6 J mice through to the F 3 generation. Three F 3 male siblings were bred to wild-type C57Bl/6 J mice to generate F 4 TDP-43 Q331K/+ mutants, which were intercrossed to generate animals for study.
Power calculations were based on historical Rotarod and touchscreen data of wild-type mice. This indicated required group sizes of 15 animals per genotype to identify a ~20% difference in performance between genotypes. Animals were only excluded from analyses if specified in the following methods.
Mouse breeding was carried out in the UK and USA. ACBM was carried out at the Brown University Rodent Neurodevelopment Behavior Testing Facility. All procedures were approved by the Brown University Animal Care and Use Committee. Touchscreen analysis, marble burying, object recognition, motor behavior, food intake and weight measurement, pathology, electrophysiology and RNA sequencing all took place in the UK. All experiments were conducted in accordance with the United Kingdom Animals (Scientific Procedures) Act (1986) and the United Kingdom Animals (Scientific Procedures) Act (1986) Amendment Regulations 2012. Animals were housed in cages of up to five animals under a 12 h light/dark cycle.
Genotyping. The Q331K mutation coincidentally introduces a SapI/EarI restriction site, which facilitates genotyping (see Supplementary Table 4 ).
Automated continuous behavioral monitoring. Ten TDP43 Q331K/Q331K and 10 wild-type animals (5 female, 5 male of each genotype) from the same breeding campaign were obtained from the animal care facility at the University of Massachusetts Medical School. Animals were group housed between sessions, but housed individually during the 5-day ACBM recording sessions. Cages were monitored with a Firefly MV 0.3 MP Mono FireWire 1394a (Micron MT9V022) at 30 frames/s. Cameras were connected to a workstation with Ubuntu 14.04 using a Firewire card to connect to all cameras. For processing by the computer vision system, all videos were downsampled to 320 × 240 pixels.
The system used for ACBM was modified from that previously described and was reimplemented in Python and NVIDIA's CUDNN to speed video analysis subroutines. All video analyses were conducted using the Brown University highperformance computer cluster. The system was retrained using data collected at the Brown Rodent Neuro-Developmental Behavior Testing facility (~20 h of video and 40 animals total). Data were annotated by hand for eight behaviors as previously described (drink, eat, groom, hang, rear, rest, sniff, walk). Accuracy was evaluated using cross-validation. The average agreement with human annotations was 78% for individual behavior and 83% overall for individual frames. Evaluation of the system was also run on a subset of the data collected for the present study, which found an overall mean agreement of 71% for individual behaviors and 82% over all video frames.
Rotarod.
Motor testing was performed using a Rotarod (Ugo Basile, model 7650, Varese, Italy). At least 24 h before testing, mice were first trained for 5 min at the slowest speed and then 7 min with acceleration. During testing mice were subjected to 7-min trials with acceleration from 3.5 to 35 r.p.m. In each session mice were tested three times with a trial separation of 30 min. The latency to fall (maximum 420 s) for each mouse was recorded and mean values for each mouse calculated. An individual mouse recording was excluded if the mouse fell off the rod while moving backwards, accidentally slipped or jumped off at slow speed. Two consecutive passive rotations were counted as a fall and the time recorded as the end point for that mouse. Mouse weights were recorded immediately after completion of Rotarod testing. All testing was conducted by operators who were blind to genotype and in a randomized order.
Feeding. Cages containing either two or three mice of the same genotype were supplied with 400 g of food on Monday mornings. The following Monday the surplus food in the hopper, together with any obvious lumps of food in the cage, was removed and weighed. The difference from 400 g was calculated and recorded as the total food consumed in 7 d. This was divided by the number of mice in a given cage. Weekly consumption was calculated for 9 consecutive weeks. Mice were 12 months of age when recording commenced. All testing was conducted while blind to genotype and in a randomized order.
Touchscreen studies. 48 male mice (n = 16 per genotype) were housed in groups of 2-5 per cage under a 12-h light/dark cycle (lights on at 7:00 pm). Testing was conducted during the dark phase. To ensure sufficient motivation, animals were food-restricted to ~85-90% of free-fed weights by daily provision of standard laboratory chow pellets (RM 3; Special Diet Services, Essex, UK). Drinking water was available ad libitum.
Experiments were performed in standard mouse Bussey-Saksida touchscreen chambers (Campden Instruments Ltd, Loughborough, UK). The reward for each correct trial was delivery of 20 μ L of milkshake (Yazoo strawberry milkshake; FrieslandCampina UK, Horsham, UK). The chambers are equipped with infrared activity beams (rear beam 3 cm from magazine port and front beam 6 cm from screen) to monitor locomotor activity.
Following 2 d of habituation to touchscreen chambers, mice underwent pretraining and training. Briefly, mice were first trained to touch the correctly lit stimulus in return for a food reward, and to initiate a trial by poking and removing their nose from the magazine. Finally, mice were discouraged from making responses at unilluminated apertures by a 5 s time-out period during which the chamber was illuminated. Investigators were blind to genotype.
Five-choice serial reaction time task (5-CSRTT). Upon completion of training at 2 s stimulus duration (baseline), mice were tested in 4 sessions of decreasing stimulus durations (2.0 s, 1.5 s, 1.0 s, 0.5 s) pseudorandomly within a session. Animals that had not reached the criterion ( > 80% accuracy, < 20% omissions in two consecutive sessions in baseline training before entering the probe test, n = 1 in the first probe test) or whose body weights were below 80% of free-feeding weight (n = 1 in the first and n = 1 in the second probe test) were excluded.
Fixed-ratio (FR) and progressive-ratio (PR) schedule. FR and PR studies were conducted as described elsewhere 52 . When performance stabilized on FR5 (completion of 30 trials within 20 min), all mice were tested on two sessions of an unrestricted FR5, which allowed an unlimited number of trials in 60 min. Next, animals underwent three sessions of PR4, in which animals need to make a progressively increasing number of responses (i.e. 1, 5, 9, 13 , … ) in each subsequent trial to obtain a single reward. PR session terminated after either 60 min or 5 min of inactivity. Breakpoint, the number of responses made to obtain the reward in the last completed trial, was recorded as an index of motivation.
Object recognition. The novel object recognition task was conducted as described elsewhere 53 in a randomized order with the operator blind to genotype and under dimmed white light. Six-month-old male mice (n = 8 or 9 per genotype) were randomly chosen from cohort 2. Mice were habituated to a Y-maze for 5 min. One day later mice were reintroduced to the Y-maze, which now contained two identical objects in each arm. Exploration time for each object over a 5 min period was recorded (sample phase). Mice were then removed from the maze and one of the objects replaced with a novel object. After a delay of 1 min or 3 h mice were reintroduced to the maze (choice phase) and the time spent exploring each object over a 5 min period was recorded. The memory for the familiar object was expressed as a discrimination ratio (difference in exploration of the novel and familiar objects divided by the total object exploration time).
Marble burying. All testing was conducted in the morning and blind to genotype. Cages of size 39.1 cm × 19.9 cm × 16.0 cm height (Tecniplast) were used. Fresh bedding material (Datesand, grade 6) was placed into each cage to a height of ~6 cm. Ten glass marbles (1 cm) were placed evenly across the bedding. Ten cages were prepared in a single round. One mouse was placed in each of the cages and the lids replaced. Mice were left undisturbed for 30 min under white light. Mice were then removed and the number of marbles buried by at least two-thirds was scored. Cages were reset using the same bedding material to test another ten mice. In stratifying mice before frontal cortical RNA-seq, animals were tested twice, 3 d apart, to identify those that consistently buried high or low numbers of marbles.
Repeat behavioral studies. Cohort 1 mice underwent Rotarod, weight, feeding and marble testing all under a standard light/dark cycle (lights on at 7:00am for 12 h). Cohort 2 mice underwent all touchscreen, object recognition and Rotarod studies under a reverse light/dark cycle.
Pathology studies. Mice were killed by cervical dislocation and tissues were processed as follows.
Brains. Right hemispheres were processed for RNA and/or protein extraction (see below). Left hemispheres were immersion-fixed in 4% paraformaldehyde (PFA) at 4 °C for 24 h, washed in PBS, cryoprotected in 30% sucrose in PBS at 4 °C, embedded and frozen in M1 matrix (Thermo Fisher Scientific) on dry ice and sectioned coronally at 16 μ m thickness on a cryostat (Leica Biosystems). Sections were mounted on Superfrost Plus charged slides (Thermo Fisher Scientific), allowed to dry overnight and stored at -80 °C.
Spinal cords. Vertebral columns were dissected, immersion-fixed in 4% PFA at 4 °C for 48 h, washed in PBS and dissected to extract spinal cords and nerve roots. The lumbar enlargement was subdissected, cryoprotected in 30% sucrose at 4 °C, embedded in M1 matrix in a silicon mold, frozen on dry ice and sectioned at 16 μ m thickness onto charged slides, briefly air dried and stored at -80 °C.
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Antigen retrieval and immunostaining. Sections were thawed at room temperature and briefly rinsed in distilled water. Antigen retrieval was performed by heating slides for 20 min at 95 °C in antigen unmasking solution, Tris-based (Vector Laboratories). Sections were cooled to room temperature, washed in distilled water, and blocked and permeabilized in a solution containing 5% bovine serum albumin (BSA), 0.1% Triton X-100 and 5% serum (specific to secondary antibody species used) for 1 h at room temperature. Slides were incubated with primary antibody for 2 h at room temperature or 4 °C overnight in fivefold-diluted blocking buffer. Secondary antibodies were applied for 1 h at room temperature (Alexa Fluor conjugated, Thermo Fisher Scientific; 1:500 in diluted block). Sections were counterstained and mounted with Vectashield hardset with DAPI (Vector Labs). Alexa Fluor 568 conjugated secondary antibodies were false-colored magenta (ImageJ 1.15j).
To quantify parvalbumin-positive neurons, parvalbumin-stained sections were imaged on a Nikon Ti-E live cell imager. Images were acquired using a Plan Apo lambda 10× objective with a final image dimension of 4,608 × 4,608 with 2 × 2 binning, stitched (NIS-Elements) and analyzed (ImageJ 1.15j) blind to genotype. For each mouse, matching sections through the frontal cortex from bregma 2.8 mm to 0.74 mm were analyzed, with a total of 10 sections per mouse quantified for 3 wild-type and 3 TDP43 Q331K/Q331K mice. Images were converted to grayscale and thresholded to produce a binary image. Consistent regions of interest were drawn around the cortex using the polygon selection tool and the 'analyze particle' function was used to count cells.
To investigate TDP-43 in parvalbumin-positive neurons, sections were co-stained with antibodies against TDP-43 and parvalbumin and imaged using a Zeiss LSM 780, AxioObserver with a Plan-Apochromat 63× /1.40 Oil DIC M27 objective running Zen system software. Data analysis (ImageJ 1.15j) and imaging was carried out blind to genotype. For each cell, a maximum intensity projection of z stacks was created and regions of interest were drawn around the nucleus and the cytoplasm using the polygon selection tool. Area, integrated density and mean gray value measurements were taken for the cytoplasm and nucleus, together with a background reading. Corrected total fluorescence for a region of interest was calculated as follows: CTF = integrated density -(area region of interest × background fluorescence) Corrected fluorescence was recorded for at least 10 cells per mouse in matched sections corresponding to bregma 1.18 mm.
To quantify AOX1 fluorescence in lumbar motor neurons, sections were co-stained with antibodies against AOX1 and neurofilament heavy chain and imaged on a Nikon Ti-E live cell imager with a Plan Apo VC 20× DIC N2 objective with a final image dimension of 1,024 × 1,024 pixels and 2 × 2 binning. Data analysis (ImageJ 1.15j) and imaging were carried out blind to genotype. Corrected fluorescence was recorded for at least 29 cells per mouse.
TDP-43 immunostaining in spinal cord and brain were imaged using a Nikon Ti-E live cell imager and a Plan Apo VC 100× Oil objective with a final image dimension of 1,024 × 1,024 pixels and 2 × 2 binning. Images are a maximum intensity z stack created using ImageJ 1.15j with a z step of 0.2 µ m.
Tau immunostaining in cortex was imaged using a Zeiss LSM 780, AxioObserver with a Plan-Apochromat 63× /1.40 Oil DIC M27 objective running Zen system software. Images are a maximum intensity z stack created using ImageJ 1.15j.
For list of primary antibodies, see Supplementary Table 5 . Lumbar spinal motor neuron quantification. Motor neurons were quantified as described elsewhere 54 . Briefly, large motor neurons (diameter > 20 μ m) in the ventral horn were counted blind to genotype in 18 sections from the lumbar L3-5 levels of each animal.
Cellular quantification in brain. Data analysis using ImageJ 1.15j and imaging was carried out blind to genotype. For total frontal cortical area, matching sections through the frontal cortex from bregma 2.8 mm to 0.74 mm were selected with a total of ten sections quantified for six wild-type and six TDP43 Q331K/Q331K mice. Matching regions of interest were drawn around the cortex and the area quantified using the 'measure' function. To count cells in cortical subregions, matching sections based on bregma references were identified. Images were converted to grayscale and thresholded to produce a binary image. Consistent regions of interest were drawn around the cortex and the 'analyze particle' function used to count cells. A minimum size of 10 pixels ensured that intact cells were counted and results were displayed with the overlay option selected.
Western blotting. Brain tissues were weighed to ensure equal amounts of starting material between samples, thawed on ice and processed using a modified fractionation protocol 55 . Briefly, tissue was sequentially homogenized and centrifuged using buffers A (NaCl 150 mM, HEPES (pH 7.4) 50 mM, digitonin (Sigma, D141) 25 μ g/mL, hexylene glycol (Sigma, 112100) 1 M, protease inhibitor cocktail (Sigma, P8340) 1% v-v) and B (same as buffer A except Igepal (Sigma, I7771) 1% v-v is used in place of digitonin) to extract cytoplasmic and membrane fractions, respectively. The subsequent pellet was sonicated in 1% sarkosyl buffer containing 10 μ M Tris-Cl (pH 7.5), 10 μ M EDTA, 1 M NaCl and centrifuged (14,000 g for 30 min at 4 °C). The supernatant was taken as the nuclear fraction. Protein lysates were quantified (bicinchoninic acid protein assay, Pierce), electrophoresed in 4-12% or 12% SDS polyacrylamide gels, wet transferred to PVDF membranes, blocked with a 50:50 mixture of Odyssey PBS blocking buffer and PBS with 0.1% Tween-20 for 1 h at room temperature and then probed with primary antibodies at 4 °C overnight. Secondary antibodies were either fluorescently tagged for Odyssey imaging or HRP-tagged for ECL visualization. Western blot band intensities were quantified using Fiji (ImageJ; Version 2.0.0rc-54/1.51 h; Build: 26f53fffab) using the programs gel analysis menu option in 8-bit grayscale. Quantification was carried out by an independent user blind to genotype. For list of primary antibodies, see Supplementary Table 5 .
Muscle histology. The right gastrocnemius was dissected, fixed in 4% PFA at room temperature, washed in PBS for 10 min twice and cryoprotected and stored in 30% sucrose with 0.1% azide. Tissues were placed in a silicone mold with M1 matrix and frozen on dry ice. Longitudinal cryosections (50 μ m) were mounted on slides (Superfrost Plus), air dried at room temperature for 5 min and stored at -80 °C.
To stain neuromuscular junctions (NMJs), slides were brought up to room temperature and incubated in blocking solution (2% BSA, 0.2% Triton X-100, 0.1% sodium azide) for 1 h. Primary antibodies against β III-tubulin (rabbit polyclonal, Sigma T2200) and synaptophysin (mouse monoclonal, Abcam ab8049) were applied at 1:200 dilution in blocking solution. Sections were incubated at room temperature overnight. Sections were washed in PBS three times and incubated for 90 min with mouse and rabbit Alexa488-conjugated secondary antibodies (Thermo Fisher Scientific) diluted 1:500 in blocking solution together with TRITCconjugated α -bungarotoxin (Sigma, T0195) 10 μ g/ml. Sections were washed in PBS and coverslipped (Vectashield hardset). Confocal z stacks were obtained using a Zeiss LSM 780 AxioObserver with a Plan-Apochromat 20× /0.8 M27 objective running Zen system software; the observer was blind to genotype.
For succinate dehydrogenase (SDH) staining, the left gastrocnemius was dissected, flash frozen in isopentane in liquid nitrogen and stored at -80 °C until use. Frozen sections of 12 μ m were prepared and stained using a modified version of a previously described method 56 . Briefly, sections were stained with freshly prepared SDH staining solution at 37 °C for 3 min, washed through saline, acetone and ethanol solutions, cleared in xylene and mounted (Permount). Images were taken using an Olympus BX41 light microscope (10× objective) with Q Capture Pro 6.0.
Quantification of NMJ innervation. NMJs from flattened z stacks of muscle were analyzed (ImageJ; Version 2.0.0-rc-54/1.51 h, build 26f53fffab) blind to genotype. Brightness and contrast thresholds were set to optimize the signal-to-noise ratio of the presynaptic staining (anti-tubulin and anti-synaptophysin). Innervated NMJs were defined as having observed overlap of staining for pre-and postsynaptic elements. Denervated NMJs were defined as α -bungarotoxin signal in the absence of presynaptic staining. A small percentage (~5% in each genotype) of NMJs could not be scored and were excluded from this analysis. Neuromuscular electrophysiology. Isolated FDB-tibial nerve preparations were mounted in an organ bath in HEPES-buffered MPS of the following composition (mM): Na + (158), K + (5), Ca 2+ (2), Mg 2+ (1), Cl -(169), glucose (5), HEPES (5), pH 7.2-7.4, and bubbled with air or 100% O 2 for at least 20 min. The distal tendons were pinned to the base of a Sylgard-lined recording chamber and the proximal tendon connected by 6/0 silk suture to an MLT0202 force transducer (AD Instruments, Oxford, UK). The tibial nerve was aspirated into a glass suction electrode and stimuli (0.1-0.2 ms duration, nominally up to 10 V) were delivered via a DS2 stimulator (Digitimer, Welwyn Garden City, UK) triggered and gated by an AD Instruments Powerlab 26 T interface. Force recordings were captured and digitized at 1 kHz using the Powerlab interface and measured using Scope 4 and Labchart 7 software (AD Instruments) running on PC or Macintosh computers. For motor unit recordings, the stimulating voltage was carefully graded from threshold to saturation to evoke the maximum number of steps in the twitch tension record. Motor unit number estimation was performed by inspection, counting the number of reproducible tensions steps, and by extrapolation between the average twitch tension of the four lowest threshold motor units and the maximum twitch tension. For tetanic stimulation, trains of stimuli 1-5 s in duration were delivered at frequencies of 2-50 Hz. To measure muscle fatigue, 50 Hz stimulus trains 1 s in duration were delivered every 5 s for about a minute. A fatigue index was calculated as the time constant of the best fitting single exponential to the decline of the maximum tetanic force. 
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Experimental design 1. Sample size
Describe how sample size was determined.
Refer to online methods: mouse breeding and maintenance: To calculate numbers of animals needed for the behavioural studies, power calculations were based on historical rotarod and touchscreen data of wild-type mice studied in the Coleman and Bussey labs respectively. This indicated required group sizes of 15 animals per genotype to pick up a ~20% difference in performance between mutant and wild-type mice.
Data exclusions
Describe any data exclusions.
